LNSR Q3 2022 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M-6.3% YoY

Gross Profit

$4M50.2% margin

Operating Income

-$4M-52.7% margin

Net Income

-$4M-51.5% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$55M

Total Liabilities

$12M

Stockholders' Equity

$43M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-6.3%
Gross Profit	$4M	$4M	+1.0%
Operating Income	-$4M	-$6M	+33.8%
Net Income	-$4M	-$6M	+35.2%

Revenue Segments

Product

$5M87%

Service

$790,00013%

Geographic Segments

UNITED STATES

$4M70%

Asia Excluding South Korea

$932,00015%

Europe

$805,00013%

Other Geographical Region

$98,0002%

KOREA, REPUBLIC OF

$74,0001%